| # | Drug | Count |
|---|---|---|
| 0 | RANITIDINE | 373 |
| 1 | RANITIDINE HYDROCHLORIDE | 136 |
| 2 | ADALIMUMAB | 36 |
| 3 | METHOTREXATE SODIUM | 31 |
| 4 | ETANERCEPT | 29 |
| 5 | METHOTREXATE | 28 |
| 6 | MEDROXYPROGESTERONE ACETATE | 27 |
| 7 | CONJUGATED ESTROGENS | 25 |
| 8 | ESTROGENS, CONJUGATED | 25 |
| 9 | INFLIXIMAB | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TELMISARTAN AND AMLODIPINE | 1 | 0.0100 |
| 1 | GLYBURIDE AND METFORMIN HYDROCHLORIDE | 1 | 0.0046 |
| 2 | RANITIDINE HYDROCHLORIDE | 136 | 0.0025 |
| 3 | RANITIDINE | 373 | 0.0019 |
| 4 | NALDEMEDINE | 3 | 0.0018 |
| 5 | FILGRASTIM-AAFI | 1 | 0.0015 |
| 6 | BRODALUMAB | 3 | 0.0015 |
| 7 | LAROTRECTINIB | 1 | 0.0011 |
| 8 | DAPRODUSTAT | 2 | 0.0010 |
| 9 | INFLIXIMAB-AXXQ | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 65 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 35 |
| 2 | Estrogen [EPC] | 32 |
| 3 | Corticosteroid [EPC] | 28 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 28 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 25 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 20 |
| 7 | GLP-1 Receptor Agonist [EPC] | 19 |
| 8 | Interleukin-23 Antagonist [EPC] | 19 |
| 9 | Loop Diuretic [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17 Receptor A Antagonist [EPC] | 3 | 0.0015 |
| 1 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 2 | 0.0009 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 14 | 0.0006 |
| 3 | Nonergot Dopamine Agonist [EPC] | 10 | 0.0006 |
| 4 | Amyloid Beta-directed Antibody [EPC] | 2 | 0.0005 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 6 | Influenza A M2 Protein Inhibitor [EPC] | 7 | 0.0004 |
| 7 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 8 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 9 | Provitamin D2 Compound [EPC] | 11 | 0.0004 |